Evidence map›Paper›PMID 30145563›Full record

ArticleAnnals of hepatology2018

Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.

James C Barton, Christine E McLaren, Wen-Pin Chen, Grant A Ramm, Gregory J Anderson, Lawrie W Powell, V Nathan Subramaniam, Paul C Adams, Pradyumna D Phatak, Lyle C Gurrin and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Iron overload and cirrhosis in referredCanadian liver journal · 2020
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 3 countries.

James C Barton
Christine E McLarenDepartment of Epidemiology, University of California, Irvine, CA, USA.
Wen-Pin ChenChao Family Comprehensive Cancer Center, Irvine, CA, USA.
Grant A RammQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Gregory J AndersonFaculty of Medicine, The University of Queensland, Herston, QLD, Australia.
Lawrie W PowellFaculty of Medicine, The University of Queensland, Herston, QLD, Australia.
V Nathan SubramaniamQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Paul C AdamsDepartment of Medicine, London Health Sciences Centre, London, ONT, Canada.
Pradyumna D PhatakRochester General Hospital, Rochester, NY, USA.
Lyle C GurrinMelbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
John D PhillipsDepartments of Medicine and Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Charles J ParkerDivision of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, UT, USA.
Mary J EmondDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Gordon D McLarenDepartment of Veterans Affairs Long Beach Healthcare System, Long Beach, CA, USA.
University of California, Irvine · USUniversity of Queensland · AUUniversity of Utah · USCommunity Cancer Center · USLondon Health Sciences Centre · CAQIMR Berghofer Medical Research Institute · AUQueensland University of Technology · AURochester General Hospital · USUniversity of Alabama at Birmingham · USUniversity of Melbourne · AUUniversity of Washington · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y HomozygotesR24DK099846 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI ADAMS, PAUL CLIFFORD, BARTON, JAMES C · 2014 to 2016
$2.0M
Regulation of Iron HomeostasisR01DK090257 · NIDDK · UNIVERSITY OF UTAH · PI PHILLIPS, JOHN DEARBORN · 2010 to 2014
$1.8M
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y HomozygotesR24DK093433 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI MCLAREN, CHRISTINE E., MCLAREN, GORDON D · 2011 to 2011
$376k
NCATS NIH HHS UL1 TR001414NCI NIH HHS P30 CA062203NIDDK NIH HHS R01 DK090257NIDDK NIH HHS R24 DK093433NIDDK NIH HHS R24 DK099846NIDDK NIH HHS U54 DK110858
6 · The paper itself

Abstract

INTRODUCTION AND

aimWe sought to identify independent risk factors for cirrhosis in HFE p.C282Y homozygotes in a cross-sectional study. MATERIAL AND

methodsWe evaluated 368 p.C282Y homozygotes who underwent liver biopsy and compared characteristics of those with and without cirrhosis. We performed multivariable logistic regression on cirrhosis with: age; sex; race/ethnicity; diabetes; blood pints/units donated voluntarily; erythrocyte pints/units received; iron supplement use; alcohol intake, g/d; body mass index, kg/m2; swollen/tender 2nd/3rd metacarpophalangeal joints; elevated alanine aminotransferase; elevated aspartate aminotransferase; steatosis/fatty liver; iron removed by phlebotomy, g; and GNPAT p.D519G positivity.

resultsMean age of 368 participants (73.6% men) was 47 ± 13 (standard deviation) y. Cirrhosis was diagnosed in 86 participants (23.4%). Participants with cirrhosis had significantly greater mean age, proportion of men, diabetes prevalence, mean daily alcohol intake, prevalence of swollen/ tender 2nd/3rd metacarpophalangeal joints, mean serum ferritin, elevated alanine aminotransferase, elevated aspartate aminotransferase, and mean iron removed; and significantly fewer mean blood pints/units donated. GNPAT p.D519G positivity was detected in 82 of 188 participants (43.6%). In a multivariable model for cirrhosis, there were four significant positive associations: age (10-y intervals) (odds ratio 2.2 [95% confidence interval 1.5, 3.3]); diabetes (3.3; [1.1, 9.7]); alcohol intake (14 g alcohol drinks/d) (1.5 [1.2, 1.8]); and iron removed, g (1.3 [1.2, 1.4]). There was no statistical evidence of two-way interactions between these variables.

conclusionIn conclusion, cirrhosis in HFE p.C282Y homozygotes is significantly associated with age, diabetes, daily alcohol intake, and iron removed by phlebotomy, taking into account the effect of other variables.

Indexed as

HomozygoteMutationAcyltransferasesAdultAge FactorsAlcohol DrinkingAustraliaComorbidityCross-Sectional StudiesDiabetes MellitusFemaleGenetic Predisposition to DiseaseHemochromatosisHemochromatosis ProteinHumansLiver CirrhosisAcyltransferasesglycerone-phosphate O-acyltransferaseHemochromatosis ProteinHFE protein, humanAlcohol intakeDiabetesIron overloadrs11558492rs1800562

Identifiers

PMID30145563
PMCPMC6368858
OpenAlexW2888316960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.